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Mutations in Inverted Formin 2 (INF2), a diaphanous formin family protein that regulates actin cytoskeleton dy-
namics, cause focal segmental glomerulosclerosis (FSGS) and Charcot–Marie–Tooth Disease (CMT) in humans. In
addition to directly remodeling actin ﬁlaments in vitro, we have shown that INF2 regulates intracellular actin
dynamics and actin dependent cellular behavior by opposing Rhoa/Dia signaling. As a step towards a better un-
derstanding of the human kidney disease, wewanted to explore the relevance of these ﬁndings to the in vivo sit-
uation. We used dose dependent knockdown of INF2 to ﬁrst deﬁne an in vivo model and establish an overt
glomerular phenotype in zebraﬁsh. This simple assay was validated by rescue with wild type INF2 conﬁrming
the speciﬁcity of the ﬁndings. The edema, podocyte dysfunction, and an altered glomerular ﬁltration barrier ob-
served in the zebraﬁsh pronephros correlate with mistrafﬁcking of glomerular slit diaphragm proteins, defective
slit-diaphragm signaling, and disinhibited diaphanous formin (mDia) activity. In contrast to wild-type human
INF2, INF2mutants associatedwith kidney disease fail to rescue the zINF2morphant phenotype. Of particular in-
terest, this INF2 knockdownphenotype is also rescued by loss of either RhoAorDia2. This simple assay allows the
demonstration that INF2 functions, at least in part, to modulate Dia-mediated Rho signaling, and that disease
causing mutations speciﬁcally impair this regulatory function. These data support a model in which disease-
associated diaphanous inhibitory domain (DID) mutants in INF2 interfere with its binding to and inhibition of
Dia, leading to uncontrolled Rho/Dia signaling and perturbed actin dynamics. Methods to ﬁne tune Rho signaling
in the glomerulus may lead to new approaches to therapy in humans.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
Inverted formin 2 (INF2) is a member of the formin family of proteins
that regulate actin dynamics (Chhabra and Higgs, 2006; Korobova et al.,
2013; Ramabhadran et al., 2011). INF2 mutations cause kidney disease
in humans characterized by focal segmental glomerulosclerosis (FSGS)
with or without Charcot–Marie–Tooth disease (Brown et al., 2010;
Barua et al., 2013; Boyer et al., 2011; Gbadegesin, 2012). Like other
formins, INF2 is a multidomain protein whose function depends on the
regulatory effect of the N-terminal Diaphanous Inhibitory Domain (DID)
on the C-terminal Diaphanous Autoregulatory Domain (DAD). In addition
to INF's direct actin polymerizing and depolymerizing activity, we have
shown that INF2 also antagonizes Rho activated actin polymerizating ac-
tivity of diaphanous related formin proteins (Dias) by the interaction of
INF2-DID with Dia DAD (Chhabra and Higgs, 2006; Sun et al., 2011).
Most of the disease-causing mutations occur in the DID, interfering with
the INF2-DID/Dia-DAD interaction. In cultured cells, we have found that
this prevents the dampening effect of INF2 on Rho/Dia signaling, leading
to imbalanced actin dynamics, perturbation of actin polymerization, and
disruption of actin based cellular remodeling processes (e.g. lamellipodia
formation and trafﬁcking to the membrane of cultured podocytes (Sun
et al., 2013)).
In vivo podocytes are highly complex epithelial cells with projec-
tions, typically referred to as foot processes thatmakeup thedistal com-
ponent of the glomerular ﬁltration barrier. The slit diaphragm, a unique
cell–cell junctional complex, is an electron dense structure visible
between neighboring foot processes (Kubiak and Niemir, 2006;
AsanumaandMundel, 2003). Both the intricatemorphology andunique
function of podocytes are dependent on the regulation of the actin cyto-
skeleton, which is under the spatial and temporal control of the Rho
family of small GTPases (Zhu et al., 2011; Scott et al., 2012; Akilesh
et al., 2011; Mouawad et al., 2013; Oh et al., 2004; Shono et al., 2009).
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Uncontrolled activation of RhoA in RhoA transgenic mice has been
shown to cause aggregation of actin bundles in podocytes, mislocation
of slit diaphragm proteins, and proteinuria (Zhu et al., 2011; Gupta
et al., 2013). Our in vitro ﬁndings indicate that INF2maintains a balance
in actin dynamics via control of Rho/Dia signaling mediated though the
DID-DAD interaction. Here we extend our studies to the in vivo func-
tional characterization of INF2 in the intact organism. We used a
zebraﬁsh model to investigate the in vivo role of INF2 and the mecha-
nism by which INF2 participates in the pathophysiology of podocyte-
mediated disease and, more generally, in nephrogenesis. We ﬁnd that
INF2 is required for normal zebraﬁsh development and, speciﬁcally,
for normal glomerular structure and function. We demonstrate that
the function of INF2 in glomerular development is largely mediated by
its effect on Rho-activated Dia signaling, as knockdown of either
zebraﬁsh Rhoa or Dia2 rescues the INF2morphant phenotype. The rela-
tive simplicity of this in vivo model of INF2-associated disease and its
rescue by transient transgenesis and gene knockdown support its utility
in examining genetic and pharmacologic modulation.
2. Materials and Methods
2.1. Zebraﬁsh, Morpholinos and PCR Primers
Experimentswere performed onwild-type zebraﬁsh (Danio rerio) in
accordancewith Institutional Animal Care andUse Committee (IACUC)-
approved protocols. The INF2 translation blocking morpholino (INF2
ATG MO) and the zINF2 exon 3 splice (INF2 E3I3) morpholino were
synthesized by Gene Tools, LLC (Philomath, OR), and titrated to 2–3
ng/embryo as the lowest concentration sufﬁcient to induce abnormal
phenotype. For each experimental group, at least 400 individual embry-
os were injected by using a micro injector PLI-90 (Harvard Apparatus,
Cambridge, MA).
Morpholinos Sequence
zINF2 ATG MO GGGCTCCCTCTGCCTTCATCGACAT
zINF2 E3I3 MO AGAGTTAAGGTCACACTTGCCTTGT
Scrambled MO CCTCTTACCTCAGTTACAATTTATA
Primers Forward/reverse
zINF2Primer1 TAGGCTCGTCTCAGGACTC/GATCACACTGAAGCGATACTGC
zINF2 Primer 2 GCCCTCAGCATGTTCTCTTC/TCTTCAAACGCCTCACACTG
zINF2 Primer 3 AAGATTGGTTCCCTGCTGAA/TGATGGTGCTGAAGAGTTCG
2.2. In Situ Hybridization
PCR product 1 was cloned into pDrive Cloning Vector (QIAGEN PCR
Cloning Kit). A digoxigenin-labeled riboprobe was generated by in vitro
transcription with T7 (antisense) or SP6 (sense) RNA polymerase
(Roche) from linearized constructs using Dig RNA labeling Mix (Roche).
Whole-mount in situ hybridizations were performed as described
(Thisse and Thisse, 2008).
2.3. In Vitro Transcription
Full-length humanﬂag-tagged INF2was subcloned frompCMV-ﬂag-
INF2 into the pxT7 vector between the KpnI and XhoI sites. The capped
and tailed mRNA of wide type and mutants of hINF2 was transcribed
from pxT7-hINF2 linearized with XbaI using the mMACHINE T7 Ultra
Kit (Ambion, USA). Embryos were microinjected with 50 pg of wide
type or mutated forms of human INF2 mRNA together with either con-
trol or INF2 morpholinos. The expression of INF2 in embryos injected
with hINF2 mRNA was conﬁrmed by Western blot using mouse-anti
FLAG M2 antibody (Sigma-Aldrich Corporation).
2.4. Transmission Electron Microscopy
As has been described, zebraﬁsh embryos were ﬁxed in 1.5% glutar-
aldehyde plus 1% paraformaldehyde in 70 mM Na2HPO4 buffer pH 7.2
plus 3% sucrose at 4 °C overnight, post-stained in 1% osmium tetroxide
in 0.1 M sodium cacodylate pH 7.4 buffer, dehydrated, inﬁltrated in a
1:1 solution of propylene oxide and EPON (Ted Pella, Inc.) and embed-
ded in EPON (Kramer-Zucker et al., 2005). Thin sections (70–80 nm)
were cut on a Reichert Ultracut E ultra-microtome and collected onto
formvar-coated slot grids. The sectionswere stainedwith uranyl acetate
and lead and examined in a Philips CM10 TEM at 80 kV.
2.5. Fluorescent Dextran Injection
1% FITC-dextran (500 kD, Molecular Probes) dissolved in PBS was
injected into the common cardinal vein of 96 hpf larvae anesthetized
with 0.2 mg/ml tricaine (3-amino benzoic acid ethyl ester, Sigma) in
egg water (Arif et al., 2013). After overnight incubation, the embryos
were ﬁxed and sectioned. Uptake of ﬁltered ﬂuorescent dextran by tu-
bular cells was evaluated in serial sections using a Nikon ﬂuorescent
microscope.
2.6. Rho Activation Assay
Using a Rho activation assay kit (Upstate Biotechnology), 50 embry-
os at 72 hpf of each groupwere homogenized on ice inMg2+ Lysis Buff-
er supplemented with Phosphatase Inhibitor Cocktail and complete
protease inhibitor cocktail (Roche LTD), spin down at 14,000 rpm at
4 °C for 10 min (Sun et al., 2011). The supernatants were collected
and incubated with Rhotekin RBD conjugated agarose at 4 °C for
15 min. The Rhotekin RBD-binding GTP Rho was measured by western
blotting using mouse-anti-Rho A, B and C antibody (EMD Millipore,
MA).
2.7. Quantiﬁcation of Membrane-associated Dia
As described previously, 50 embryos at 72 hpf of each group were
homogenized in cold homogenization buffer (10 mM Tris–HCl, pH 7.5;
1 mM EGTA; 1 mMMgCl2) supplemented with complete protease in-
hibitor cocktail (Roche LTD) (Sun et al., 2013). The lysates were centri-
fuged at 50,000 g and 4 °C for 60 min to pellet membrane fractions in a
Beckman Optima TLX ultracentrifuge with TLA45 rotor (Beckman Coul-
ter, Inc.). The pellets were dissolved in 1% SDS in buffer A (50 mM Tris–
HCl, pH 7.5; 140mMNaCl; 10% glycerol; 1% Triton X-100) supplement-
ed with protease inhibitor cocktail. Dia2 protein in the whole lysates
and the membrane fractions were measured by Western blotting (rab-
bit anti-Dia2, Santa Cruz Biotechnology, Inc). The fraction ofmembrane-
associated Dia2 was expressed as the percentage of total Dia2.
2.8. CD16/CD7/NCD Crosslink Assay
A conditionally immortalized human podocyte cell line (Saleem
et al., 2002) was maintained in RPMI1640 with 10% FBS, Insulin–trans-
ferrin–selenium (Gibco), and 50 IU/ml penicillin–streptomycin at 33 °C.
Podocytes at permissive condition were transfected with plasmids
encoding GFP-NCK1 and CD16/CD7/Nephrin cytoplasmic domain
(NCD) or CD16/CD7/HA (gift of Dr. Lawrence Holzman, University of
Pennsylvania). 24 h later, the cells were incubated in RPMI 1640 con-
taining mouse anti-CD16 (Santa Cruz Biotechnology, Inc) at 37 °C for
1 h and then with in RPMI 1640 containing 1 μg/ml of Alexa Fluor594-
conjugated goat anti-mouse IgG (Molecular Probes) for 1 h. Then the
cells were ﬁxed in 4% paraformaldehyde. Filamentous actin was visual-
ized with Alexa Fluor 350-conjugated phalloidin (Molecular Probes).
After mounting, the cells were observed under a confocal microscope.
Podocyte expressing CD16/CD7/HA instead of CD16/CD7/NCD or
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podocytewithout crosslink serve as two negative controls to ensure the
speciﬁcity of the crosslink assay.
2.9. Immunohistochemical Staining
The parafﬁn embedded control or INF2 morphants at 72 hpf were
microsectioned to a thickness of 3 μm. The transverse sections
were deparafﬁnized, dehydrated, and followed by antigen retrieval
(autoclaved for 3 min in 0.01 M citric acid buffer). The endogenous
peroxidase was inactivated by 3% hydrogen peroxide. After blocking
in 5% BSA in PBS, sections were incubated in rabbit anti INF2 (dilu-
tion 1:200, Sigma-Aldrich Corporation HPA000724), biotinylated
anti-rabbit IgG, streptavidin HRP complex successively. Color reac-
tionwas developed by applying HRP substrate and 3,3′-Diaminoben-
zidine (DAB). After co-stain with hematoxylin, the sections were
examined under light microscopy. For immunoﬂuorescence staining
of nephrin, after blocking in 5% BSA in PBS, sections were incubated
in rabbit anti nephrin (dilution 1:200, gift of Dr. Tomoko Obara
(Ichimura et al., 2013)), and then with Alexa Fluor 594-conjugated
goat anti-rabbit IgG (Molecular Probes).
3. Results
3.1. INF2 Expression in Zebraﬁsh
Blast analysis of human INF2 protein sequence in the Zebraﬁsh
Model Organism Database (ZFIN) identiﬁed a single close homolog of
mammalian INF2 (ENSDARG00000015102, location Zv9_scaffold3548,
66% identical at the amino acid level), in contrast to the next best
matches which were less than 30% identical. The amino acid sequence
similarity of these homologs in zebraﬁsh (Uniprot ID: H9GX54),
human (Uniprot ID: Q27J81) and mouse (Uniprot ID: Q0GNC1) was
compared using Multiple Sequence Alignment software ClustalW2
(Fig. 1a, http://www.ebi.ac.uk/Tools/msa/clustalw2/). The transcription
and the expression of zINF2 at different stages of development were de-
termined by RT-PCR and byWestern blot (Fig. 1). As shown in Fig. 2a–c,
in situ hybridization shows zINF2 transcription in the nervous system
Fig. 1. INF2 expression in zebraﬁsh. a. Sequencing alignment of INF2 protein in zebraﬁsh, human and mouse. The INF2 sequence similarity in zebraﬁsh (Uniprot ID: H9GX54), human
(Uniprot ID: Q27J81) andmouse (Uniprot ID: Q0GNC1)was done by usingMultiple Sequence Alignment software ClustalW2. The highlighted FSGS-causingmutations occur in evolution-
arily conserved residues within the DID of INF2. b. Schematic showing zINF2 transcription targeted by ATG translational blocking morpholino (ATG MO) or by exon E3I3 junction
morpholino (E3I3 MO) resulting in exon 3 skipping, introducing an early stop codon and a short truncation. c. The transcription of zINF2 was measured by RT-PCR at different stages
of development (24, 48, 72 hpf) by using 3 pairs of primers (p1, p2, and p3). Selective targeting of zINF2 by E3I3 morpholino was conﬁrmed by RT-PCR using primer pair 1 ﬂanking
exon 3, which yield a shorter product (519 bp) compared to control morpholino (403 bp). d. The decreased expression of zINF2 protein in zINF2 ATG translation blocking morphants
or E3I3 morphants was conﬁrmed by western blotting.
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(NS), eyes, somites, and vessels at the early stage of development (24
hpf), as well as signiﬁcant transcription in kidney primordial at 48 hpf.
Immunohistochemistry stain illustrates the expression of INF2 at ner-
vous system, glomerulus, tubules, liver, and gut at 72 hpf (Fig. 2d and e).
3.2. Selective Targeting of zINF2 Causes Embryo Malformation and
Impaired Nephrogenesis
A morpholino targeting the translation start ATG (ATG translational
blocking MO, or ATG MO) and an alternative morpholino targeting the
exon3–intron3 splice site (E313 MO) of zINF2 were used to interfere
with the transcription of the gene (Fig. 1b). A standard scrambled
morpholino provided by GeneTools served as a control (C-MO). This
morpholino has no target or signiﬁcant biological activity. Using a prim-
er pair that ﬂanks Exon3 (Fig. 1b), we ampliﬁed a spliced product of
400 bp in E3I3 morphants, compared to a product of 500 bp in control
embryos (Fig. 1c). As indicated by sequencing of the PCR ampliﬁed
products, the E3I3 MO interferes with the splicing of zINF2 mRNA,
leads to exon 3 skipping, introduces an early stop codon and results in
a truncated peptide (Fig. 1b). In situ hybridization (Fig. 2a) andWestern
blot (Fig. 1d) demonstrated decreased transcription and expression of
zINF2 in INF2 morphants when compared with control embryos.
INF2 morphants exhibit an edematous phenotype with various de-
grees of dorsalization and an underdeveloped kidney on morphologic
assessment (Fig. 3). We categorized each of the INF2 morphants into
one of four phenotypes: 0, no signiﬁcant difference vs. control; 1, peri-
cardial edema; 2, diffuse edema with signiﬁcant dorsalization; and 3,
diffuse edema, more extensive dorsalization. The INF2 morphants
showed markedly increased edema and glomerulosclerosis (Fig. 3).
To conﬁrm that the morphogenetic defects in zebraﬁsh were in fact
caused by the selective targeting of INF2, we co-injected in vitro tran-
scribed human INF2 mRNA (hINF2) together with the zINF2 ATG MO
(Fig. 3). We found that the malformation of INF2 morphants could be
largely rescued by the expression of wild-type hINF2, but neither
E184K nor R218Q point mutant forms of hINF2 (which disrupt the
INF2/Dia interaction) were able to rescue the phenotype (Sun et al.,
2011, 2013). Embryos injected with the control morpholino (C-MO,
solid line group) together with hINF2 mRNA (wild-type or mutant)
did not show any signiﬁcant morphogenetic defects suggesting that
while these FSGS-causing INF2 mutations cause a dominantly inherited
human disease, they do not act in a purely dominant gain-of-function
manner (Fig. 3).
3.3. INF2 Knockdown in Zebraﬁsh Causes Slit Diaphragm Deformity and
Dysfunction
The INF2 morphants at 96 hpf develop an edematous phenotype
with abnormal glomerulus and tubules (Fig. 5). Electron microscopy
of the control embryos demonstrated uniform podocyte foot processes
along the glomerular basement membrane (GBM). In INF2 morphants
at the same developmental stage, we observed irregular cytoplasmic
protrusions (i.e. jumbled foot processes) with crowded microvillus
structures adjacent to an unevenGBM. In thesemorphant ﬁsh the inter-
cellular and cell–matrix orientations were both disrupted, accompanied
by absence of distinct slit diaphragms (Fig. 4).
To evaluate the ﬁltration function of the glomerulus, we injected
FITC labeled dextran (500 kd) into the cardinal vein of INF2 morphants
or control embryos at 96 hpf (Fig. 5) (Arif et al., 2013).We observed the
Fig. 2. INF2 ﬁsh expression in zebraﬁsh as detected by in situ hybridization and immunohistochemistry. a. The transcription of zINF2 at different stages of development was illustrated by
using in situ hybridization (sense probe serving as a control). b. Detailed localization of INF2 transcription in wt zebraﬁsh. c. A transverse section at kidney plane shows INF2 mRNA tran-
scription (sense probe as a control). Immunohistochemistry stain shows INF2 expression in zebraﬁsh at sagittal, transverse sections (d) and at kidney plane (PBS instead of 1st antibody
was used in control sections). NS: nervous system; L: liver; G: Glomerulus; T: tubules.
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accumulation of FITC-dextran in the pronephric tubular cells of INF2
morphants when compared with the tubules in control embryos, indi-
cating increased permeability of the glomerular ﬁltration barrier in the
INF2 morphants (Fig. 5).
3.4. INF2 Knockdown in Zebraﬁsh Results in Mistrafﬁcking of Slit
Diaphragm Protein
The jumbled podocyte foot processes and loss of slit diaphragms in
INF2 morphants suggest a role for INF2 in the maintenance of these in-
tercellular junctions. We examined the expression of nephrin, a trans-
membrane protein unique to the podocyte slit diaphragm with both
structural and signaling roles. In cultured human podocytes, nephrin lo-
calizes to the lamellepodial edge with enrichment at the intercellular
junctions along the interdigital processes (Fig. 4), compared to the deﬁ-
cient nephrin trafﬁcking in podocytes treated with INF2 siRNA. In our
in vivo zebraﬁsh model, nephrin exhibits a linear distribution along
the capillary tufts in the control glomeruli compared with a patchy
granular distribution of nephrin in the glomeruli of INF2morphants
(Fig. 4).
3.5. INF2 Depletion in Podocytes Disrupts Slit Diaphragm Signaling
Nephrin pairing at the slit diaphragm initiates the phosphorylation
of nephrin's cytoplasmic domain, which recruits additional signaling
molecules (for example, Nck1 and 2) that then induce actin remodeling.
We used an established antibody-induced nephrin cytoplasmic domain
(NCD) crosslinking assay (Fig. 6a) to investigate the role of INF2 in the
integrity of the slit diaphragm signaling (Verma et al., 2006). CD16/
NCD crosslinking results in the formation of a so-called nephrin
signalsome (red) characterized by GFP-Nck (green) recruitment and
actin tail formation (blue tails marked by arrows, Fig. 6b and d). As
negative controls, we used either podocytes without crosslinking or
podocytes expressing CD16/CD7/HA rather than CD16/CD7/NCD. No
actin tails form in either of these control conditions (Fig. 6b). Knock-
down of INF2 led to the disruption of normal nephrin signaling charac-
terized by both defective Nck recruitment and loss of actin tail
formation at the clustered nephrin (Fig. 6c and d).
3.6. INF2 Antagonizes Rho/Dia Signaling During Zebraﬁsh Development
As shown in Fig. 3, the membrane association of zDia (indicating the
activation of Dia) was signiﬁcantly increased in INF2 morphants com-
pared to the amount ofmembrane zDia seen in control embryos, despite
similar levels of Rho activity as measured by a Rhotekin RBD pulldown
assay (Fig. 3e). The co-expression of wild-type hINF2 largely corrected
the phenotype of INF2 morphants and restored the uncontrolled Dia
activity in comparison to the sustained Dia activation seen in INF2
morphants expressing E184K or R218Q forms of hINF2, two FSGS-
causing mutations that disrupt the inhibitory effects of INF2 on Dia.
We next co-injected INF2 ATG MO with a morpholino designed to
inactivate either zebraﬁsh RhoA (Zhu et al., 2008) (MO4-Rhoab
sequence from http://zﬁn.org/ZDB-MRPHLNO-080923-1) or zebraﬁsh
Dia2 MO (Lai et al., 2008) (DIAPH2-001, ENSDART00000147443,
ATG translational blocking MO sequence from http://zﬁn.org/ZDB-
MRPHLNO-090115-1), in order to conﬁrm that the alterations seen in
INF2morphants are a result of INF2's role in opposing Rho/Dia signaling.
Subthreshold doses of Rhoa MO (2 ng/embryo) or Dia2 MO (2 ng/em-
bryo), either of which alone does not induce a signiﬁcant phenotype,
was co-injected with INF2 ATG MO (2 ng/embryo) or control MO (2
ng/embryo). The survival rates and phenotype distributions were com-
pared at 72 hpf (Fig. 7). Co-injection of Rhoa or Dia2 largely rescued the
abnormal morphogenesis phenotypes and reduced survival induced by
INF2 morpholinos.
Fig. 3. Zebraﬁsh phenotype associatedwith INF2 expression and Dia activity. ControlMO and INF2ATGMOand in vitro transcribed hINF2mRNAswere co-injected into zebraﬁsh embryos
at the single-cell stage. a, b, c. 400 zebraﬁsh expressing different forms of INF2 (50 per group) were categorized and quantiﬁed based on different gross phenotype and histology at 96 h
post fertilization (hpf). Phenotype 0: grossly and histologically identicalwithwtﬁsh at 96 hpf; phenotype 1: signiﬁcant pericardia edema, slightly disorganized sarcomeres at the tip of the
tails, without signiﬁcant tail curling or dorsalization. Histologically collapsing or underdeveloped glomerular tufts.; phenotype 2: Diffuse edemawith prominent yolk, signiﬁcant bending
and dorsalization. Histologically, underdeveloped glomerulus without open capillary tuft.; phenotype 3: dorsalized embryo with shortened tail, diffuse edema, underdeveloped proneph-
ros, and distended tubules. Statistical signiﬁcance, χ2 test: *, p b 0.05 vs. C-MO only; ^, p b 0.05 vs. ATG-MO only. d. Expression of hINF2 protein (Flag-tagged) was conﬁrmed by western
blot in 50 zebraﬁsh in each group. e. Rho activity in zebraﬁsh with expression of different forms of INF2 was measured by Rhotekin RBD pulldown assay. f. Dia activity in zebraﬁsh with
different manipulations of INF2 was measured and quantiﬁed as the ratio of membranous associated Dia2 (Membrane/Total Dia2).
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4. Discussion
Our analysis of an INF2 deﬁcient zebraﬁsh model shows that INF2 is
essential for normal embryonic development in zebraﬁsh, and speciﬁcally
for the development and maintenance of the integrity of the glomerular
ﬁltration barrier. Loss of INF2 function leads to a nephrosis-like edema-
tous phenotype with podocyte abnormalities accompanied by both mal-
formation and malfunction of the glomerular ﬁltration barrier.
The podocyte, a highly differentiated glomerular epithelial cell,
makes up the most distal portion of the kidney ﬁltration barrier.
Recent studies show that Rho GTPase plays a key role in maintaining
podocyte morphology and function (Wang et al., 2012). Excess acti-
vation of RhoA in podocytes induces proteinuria and FSGS (Zhu et al.,
2011). Our earlier studies in cultured podocytes demonstrated that
INF2 modulates Rho/Dia signaling by binding to and antagonizing
the actin polymerizing activity of Dia, a major downstream effecter
of RhoA. Here we demonstrate that the activity of Dia, as measured
by its membrane association, correlates with the severity of the
observed INF2-deﬁcient zebraﬁsh phenotype, despite the absence
of signiﬁcant Rho activation. These data suggest that INF2 likely
Fig. 4. INF2 knockout leads to altered podocyte structure and nephrin mistrafﬁcking. a. Ultrastructure of glomerulus and podocyte in INF2 morphant zebraﬁsh vs. control ﬁsh. b. Cultured
podocytes were transfected with INF2-targeting siRNA or a control RNA duplex (control siRNA) for 48 h. Then the cells in both groups were transfected with a plasmid encoding human
nephrin. 24 h later, nephrin expressionwas illustrated by immunoﬂuorescence stain in cultured podocyte with INF2 knockdown (INF2 siRNA) vs. control cells (control siRNA). c. Glomer-
ular section of INF2 morphants (INF2 MO) and control ﬁsh (control MO). The expression of nephrin is illustrated using immunoﬂuorescence staining in the zebraﬁsh glomerulus (INF2
morphants (INF2 MO) vs. control ﬁsh (control MO)).
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functions though the direct opposition of the Dia protein, rather than
through activation of Rho.
Ultrastructurally, the podocytes of INF2 morphants lose the normal
regularity of podocyte foot processes andnormal slit diaphragmstructure.
Instead, they exhibit jumbled protrusions with prominent microvillus
formation and loss of normally oriented slit diaphragms. Microvilli are
ﬁnger-like membrane protrusions with central actin bundle elongation
characterized by Dias localized to the tip of these protrusions and consis-
tent with excess Rho/Dia signaling in these INF2 morphants (Ridley,
2006). Trafﬁcking of nephrin to speciﬁc membrane domains of precursor
podocytes during development has been shown to initiate foot process
budding and intracellular junction formation (slit diaphragms) (George
and Holzman, 2012). Mistrafﬁcking of slit diaphragm proteins may result
from unbalanced Rho/Dia signaling in podocytes with INF2 deﬁciency
(Sun et al., 2013; Homem and Peifer, 2009; Wallar et al., 2007). In the
present studies, we found a signiﬁcant change in nephrin trafﬁcking in
INF2morphant zebraﬁsh. Theseﬁndings suggest that uncontrolledDia ac-
tivity in the absence of INF2 contributes to the abnormal development of
the glomerular ﬁltration barrier, caused at least in part by defective traf-
ﬁcking of slit diaphragm proteins.
In addition to the mistrafﬁcking of nephrin in cultured podocytes
with INF2 knockdown and in INF2 morphant zebraﬁsh, we also found
loss of the normal signaling pattern from the slit diaphragm complex
that is normally initiated by nephrin crosslinking. Defective recruitment
of signaling components and loss of the usual actin tail formation at the
nephrin signalosome were observed in INF2 deﬁcient podocytes,
indicating a critical role for INF2 in maintaining the function of the slit
diaphragm and glomerular ﬁltration barrier.
The defective phenotype of these zINF2 morphants was efﬁciently
rescued by the wild-type hINF2 but not by disease-causing mutant
forms E184K, R218Q. This ﬁnding is consistent with the model that
human disease-causing mutations located within the DID of INF2 act,
at least in part, via the loss of INF2-mediated dampening of Rho/Dia
activity. We observed that knockdown of either RhoA or Dia2was sufﬁ-
cient rescue the zINF2morphant phenotype. This supports the idea that
the pathologic effects of INF2 loss of function are mediated, at least in
part, by loss of inhibition of Rho/Dia signaling.
We used morpholinos rather than gene editing technologies to
explore the relationship between INF2 dose and the ﬁnal output of
the in vivo assays. While there may sometimes be issues with the
speciﬁcity of morpholinos, these are allayed in this case by the preci-
sion of the ﬁnal phenotype, the initial titration dose response curves
and the effective rescue by wildtype human INF2. Subsequent exper-
iments were performed using doses of morpholino that were well
below those at which any potential non-speciﬁc phenotypes were
observed and where there was complete rescue with wild type
INF2 RNA.
In summary, our studies demonstrate that INF2 dampens Rho/Dia
mediated actin dynamics and actin-dependent behaviors in vivo. By
means of this activity, INF2 preserves the oriented trafﬁcking of glomer-
ular slit diaphragm proteins and the integrity of signaling at the slit
diaphragm complex. Without the counterbalancing effects of INF2,
Fig. 5. INF2 knockout in zebraﬁsh results in slit diaphragm dysfunction. Control and INF2 morphants were examined for the effect of INF2 knockdown on the gross phenotype (a) and
histology of glomerulus (G) (b). At 96 hpf, FITC-labeled dextran was injected into the cardinal vein of the ﬁsh. 24 h later, ﬁsh were sacriﬁced and sections at the kidney plane were exam-
ined under light microscopy (b) and ﬂuorescence microscopy (c). Uptake of injected FITC-dextran in tubular cells indicates the increased leakage of molecules through the glomerular
ﬁltration barrier with INF knockdown (d. magniﬁed tubular cells, INF2 MO vs. Control MO). G denotes glomerulus, T denotes tubule.
113H. Sun et al. / EBioMedicine 1 (2014) 107–115
Rho/Dia signaling is not restrained, resulting in both structural and
functional abnormalities of the podocyte as well as failure to establish
a deﬁnitive glomerular ﬁltration barrier. These ﬁndings help elucidate
the regulatory mechanisms governing Rho activity in general and
Rho-regulated glomerular function in particular. These results also add
to a growing body of literature regarding the complexity and regulatory
interactions governing small GTPases, cytoskeletal regulation and their
relevance to human disease. Given that podocyte dysfunction is a com-
mon feature ofmost proteinuric forms of kidney disease, understanding
the mechanisms of podocyte injury, and how the effectors of mecha-
nisms might be modulated for therapeutic beneﬁt, we believe that
these experiments provide new clues as to how Rho-mediated injury
might be modulated.
The simple zebraﬁsh model that we employ here should be useful
for both the further dissection of the biological pathways involved in
INF2 mediated human glomerular disease, and perhaps INF2 mediated
neurological disease as well. The unique characteristics of zebraﬁsh
should alsomake this a useful model for the identiﬁcation of pharmaco-
logic agents that modify these diseases.
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Fig. 6. INF2 depletion in culturedpodocytes destroys the integrity of slit diaphragmsignaling. a. Schematic of CD16/Nephrin cytoplasmic domain (NCD) crosslinkmodel. In culturedhuman
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crosslinking, leading to loss of normal of slit diaphragm signaling.
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